Transforming advanced therapies into clinical reality
Built on 15+ years of proven GMP expertise in advanced cell therapy manufacturing
Advanced Therapy Manufacturing Platform
Citospin operates one of Spain’s most established ATMP manufacturing platforms, built within the country’s first clean room dedicated exclusively to advanced therapies. With more than 3,000 MSC treatments manufactured and over 20 clinical trials supported, our platform combines scientific expertise with GMP-grade precision.
Development & Clinical Manufacturing Services
We act as a strategic partner for advanced therapy programs, supporting process development, GMP manufacturing, regulatory documentation, and clinical supply coordination. Our experience spans autologous and allogeneic workflows, ensuring reliable execution from early development through clinical-stage production.
Emerging Programs & Innovation Pipeline
While our current clinical platform centers on bone marrow–derived MSCs, Citospin is actively expanding its research and development capabilities to support the next generation of advanced biological therapies.
Why Partner With Citospin